Complete Filing Data
Health In Tech, Inc. reported Stockholders Equity of $17.11 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Health In Tech, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | $1.3M | $670.5K | $4.0M |
| Selling And Marketing Expense | $4.2M | $3.2M | $3.4M |
| Revenues | $33.3M | $19.5M | $19.2M |
| Research And Development Expense | $1.6M | $2.8M | $2.0M |
| Operating Expenses | $19.4M | $14.4M | $13.5M |
| Nonoperating Income Expense | $145.7K | -$100.9K | $38.8K |
| Income Tax Expense Benefit | $395.3K | $218.5K | $945.2K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $1.7M | $889.0K | $3.4M |
| Gross Profit | $20.9M | $15.4M | $16.8M |
| General And Administrative Expense | $13.7M | $8.5M | $8.1M |
| Cost Of Revenue | $12.4M | $4.1M | $2.3M |
| Deferred Income Tax Liabilities Net | $757.7K | $328.7K | $422.0K |
| Deferred Income Tax Expense Benefit | $429.0K | -$93.3K | $134.0K |
| Interest Expense Nonoperating | $495.0K | $2.1K | |
| Income Taxes Paid Net | $830.7K | $558.5K | $479.2K |
| Other Nonoperating Income | $118.4K | $271.2K | |
| Accrued Income Taxes Current | $205.3K | ||
| Other Nonoperating Expense | $382.6K | ||
| Net Income Loss Available To Common Stockholders Basic | $670.5K | $2.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | $452.2K | $630.6K | $498.6K | $376.1K | $338.0K | $100.5K |
| Selling And Marketing Expense | $962.6K | $1.2M | $1.1M | $508.5K | $974.5K | $1.0M |
| Revenues | $8.5M | $9.3M | $8.0M | $4.5M | $5.0M | $5.1M |
| Research And Development Expense | $235.8K | $582.6K | $537.7K | $718.4K | $701.6K | $760.2K |
| Operating Expenses | $4.7M | $5.6M | $4.9M | $3.0M | $3.5M | $3.8M |
| Nonoperating Income Expense | $106.7K | $108.2K | $203.8K | -$32.1K | -$133.7K | -$140.7K |
| Income Tax Expense Benefit | $148.0K | $202.6K | $185.8K | $30.7K | $63.3K | $91.2K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $600.2K | $833.3K | $684.4K | $406.7K | $401.3K | $191.7K |
| Gross Profit | $5.1M | $6.3M | $5.4M | $3.5M | $4.0M | $4.1M |
| General And Administrative Expense | $3.5M | $3.8M | $3.2M | $1.8M | $1.8M | $2.0M |
| Cost Of Revenue | $3.3M | $3.0M | $2.7M | $979.6K | $974.7K | $989.9K |
| Deferred Income Tax Liabilities Net | $274.8K | $262.1K | $294.2K | |||
| Deferred Income Tax Expense Benefit | -$34.5K | -$60.1K | ||||
| Interest Expense Nonoperating | $165.0K | $165.0K | $165.0K | |||
| Income Taxes Paid Net | $39.2K | |||||
| Other Nonoperating Income | $118.4K | $157.2K | ||||
| Accrued Income Taxes Current | $34.9K | $425.6K | ||||
| Other Nonoperating Expense | $5.0K | $62.8K | ||||
| Net Income Loss Available To Common Stockholders Basic |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity * | $17.1M | $13.2M | $6.1M | $1.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.7M | $7.8M | $2.4M | $1.5M |
| Retained Earnings Accumulated Deficit | $5.2M | $3.9M | $3.3M | |
| Prepaid Expense And Other Assets Current | $3.3M | $787.2K | $264.4K | |
| Other Receivables Net Current | $3.5M | $500.3K | $1.7M | |
| Operating Lease Right Of Use Asset | $139.9K | $206.3K | $266.6K | |
| Operating Lease Liability Noncurrent | $63.6K | $139.8K | $206.7K | |
| Operating Lease Liability Current | $76.2K | $66.9K | $58.5K | |
| Liabilities Noncurrent | $821.3K | $468.5K | $628.7K | |
| Liabilities Current | $5.2M | $2.1M | $4.8M | |
| Liabilities And Stockholders Equity | $23.1M | $15.8M | $11.5M | |
| Liabilities | $6.0M | $2.6M | $5.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$179.5K | $5.4M | $928.4K | |
| Cash And Cash Equivalents At Carrying Value | $7.7M | $7.8M | $2.4M | |
| Assets Noncurrent | $6.9M | $5.0M | $4.6M | |
| Assets Current | $16.2M | $10.8M | $6.9M | |
| Assets | $23.1M | $15.8M | $11.5M | |
| Accounts Receivable Net Current | $756.3K | $1.6M | $2.2M | |
| Accounts Payable And Accrued Liabilities Current | $4.2M | $1.9M | $2.6M | |
| Notes And Loans Receivable Net Noncurrent | $816.0K | $816.0K | ||
| Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | $38.4K | $50.0K | ||
| Additional Paid In Capital Common Stock | $11.8M | $9.2M | ||
| Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | $39.8K | |||
| Provision For Refund Liability | $3.9M | |||
| Deferred Offering Costs | $171.0K | $261.8K | ||
| Amortization Of Debt Discount Premium | $495.0K | |||
| Repayments Of Notes Payable | $2.1M | $495.0K | ||
| Other Liabilities Current | $891.6K | |||
| Taxes Payable Current | $205.3K | $451.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $17.2M | $16.4M | $14.2M | $6.9M | $6.5M | $6.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.0M | $8.1M | $7.6M | $1.7M | $2.2M | $1.4M |
| Retained Earnings Accumulated Deficit | $5.5M | $5.1M | $4.4M | |||
| Prepaid Expense And Other Assets Current | $2.1M | $1.5M | $1.8M | |||
| Other Receivables Net Current | $3.9M | $3.9M | $4.0M | |||
| Operating Lease Right Of Use Asset | $157.1K | $173.9K | $190.3K | |||
| Operating Lease Liability Noncurrent | $83.8K | $102.9K | $121.6K | |||
| Operating Lease Liability Current | $73.8K | $71.4K | $69.1K | |||
| Liabilities Noncurrent | $358.6K | $365.1K | $415.8K | |||
| Liabilities Current | $5.2M | $5.4M | $6.8M | |||
| Liabilities And Stockholders Equity | $22.8M | $22.2M | $21.3M | |||
| Liabilities | $5.6M | $5.8M | $7.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$274.2K | -$1.1M | ||||
| Cash And Cash Equivalents At Carrying Value | $8.0M | $8.1M | $7.6M | |||
| Assets Noncurrent | $7.7M | $7.3M | $5.8M | |||
| Assets Current | $15.0M | $14.9M | $15.6M | |||
| Assets | $22.8M | $22.2M | $21.3M | |||
| Accounts Receivable Net Current | $868.6K | $1.3M | $2.1M | |||
| Accounts Payable And Accrued Liabilities Current | $4.3M | $4.3M | $5.5M | |||
| Notes And Loans Receivable Net Noncurrent | $864.0K | $848.0K | $832.0K | |||
| Accrued Development Of Software Included In Accounts Payable And Accrued Expenses | $256.1K | $9.5K | ||||
| Additional Paid In Capital Common Stock | $11.6M | $11.3M | $9.7M | |||
| Accrued Deferred Offering Costs Included In Accounts Payable And Accrued Expenses | $33.3K | $110.0K | ||||
| Provision For Refund Liability | $955.7K | $780.0K | ||||
| Deferred Offering Costs | $166.0K | $66.5K | $91.5K | |||
| Amortization Of Debt Discount Premium | $165.0K | |||||
| Repayments Of Notes Payable | ||||||
| Other Liabilities Current | $869.1K | $955.7K | $780.0K | |||
| Taxes Payable Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Payments To Develop Software | $3.2M | $900.8K | $1.1M |
| Payments Of Deferred Offering Costs | $210.8K | $2.0M | $261.8K |
| Net Cash Provided By Used In Operating Activities | $3.1M | $2.2M | $1.5M |
| Net Cash Provided By Used In Investing Activities | -$3.1M | -$836.8K | -$1.9M |
| Net Cash Provided By Used In Financing Activities | -$187.4K | $4.1M | $1.3M |
| Increase Decrease In Other Receivables | $3.3M | -$1.2M | $1.7M |
| Increase Decrease In Accrued Income Taxes Payable | -$205.3K | -$246.7K | $332.0K |
| Increase Decrease In Accounts Receivable | -$907.0K | -$586.7K | $1.3M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.4M | -$852.0K | $2.1M |
| Stock Issued During Period Value Share Based Compensation | $2.6M | $468.5K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.9M | $514.2K | |
| Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | $551.00 | -$1.9K | |
| Depreciation Depletion And Amortization | $900.6K | $541.1K | |
| Share Based Compensation | $1.6M | $468.5K | |
| Proceeds From Sale Of Loans Receivable | $64.0K | $64.0K | |
| Proceeds From Issuance Of Common Stock | $8.2M | ||
| Proceeds From Notes Payable | $1.7M | ||
| Increase Decrease In Prepaid Expenses Other | $514.2K | $211.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|
| Payments To Develop Software | $703.5K | $133.4K | ||
| Payments Of Deferred Offering Costs | $98.1K | $243.2K | ||
| Net Cash Provided By Used In Operating Activities | $527.4K | -$680.2K | ||
| Net Cash Provided By Used In Investing Activities | -$703.5K | -$133.4K | ||
| Net Cash Provided By Used In Financing Activities | -$98.1K | -$243.2K | ||
| Increase Decrease In Other Receivables | $3.5M | -$237.1K | ||
| Increase Decrease In Accrued Income Taxes Payable | $220.3K | $112.0K | ||
| Increase Decrease In Accounts Receivable | $463.5K | -$221.1K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $3.4M | -$1.5M | ||
| Stock Issued During Period Value Share Based Compensation | $283.2K | $1.6M | $493.2K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.0M | $90.0K | ||
| Increase Decrease In Operating Lease Rightofuse Assets And Liabilities Net | -$19.00 | -$624.00 | ||
| Depreciation Depletion And Amortization | $136.0K | $134.8K | ||
| Share Based Compensation | $493.2K | |||
| Proceeds From Sale Of Loans Receivable | ||||
| Proceeds From Issuance Of Common Stock | ||||
| Proceeds From Notes Payable | ||||
| Increase Decrease In Prepaid Expenses Other |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 55.8M | 51.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 57.7M | 53.7M |
| Earnings Per Share Diluted | $0.02 | $0.01 |
| Earnings Per Share Basic | $0.02 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 56.4M | 55.4M | 54.6M | 51.8M | 51.8M | 51.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 58.8M | 55.6M | 57.0M | 51.8M | 51.8M | 51.8M |
| Earnings Per Share Diluted | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Earnings Per Share Basic | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Investment Income Interest | $409.9K | $122.9K | $40.9K |
| Interest Income Other | $64.0K | $64.0K | $16.0K |
| Capitalized Computer Software Net | $6.5M | $4.0M | $3.6M |
| Provision For Doubtful Accounts | -$16.2K | $1.9K | |
| Prepaid Expense Noncurrent | $258.2K | ||
| Stock Issued During Period Value New Issues | $5.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Investment Income Interest | $111.7K | $108.2K | $85.4K | $38.5K | $31.3K | $24.3K |
| Interest Income Other | $16.0K | $16.0K | ||||
| Capitalized Computer Software Net | $6.2M | $5.5M | $4.7M | |||
| Provision For Doubtful Accounts | ||||||
| Prepaid Expense Noncurrent | $504.8K | $783.6K | ||||
| Stock Issued During Period Value New Issues |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.